Franziska Michor
Franziska Michor
Associate Professor of Biostatistics, Harvard University
Verified email at - Homepage
Cited by
Cited by
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
Y Wang, J Waters, ML Leung, A Unruh, W Roh, X Shi, K Chen, P Scheet, ...
Nature 512 (7513), 155-160, 2014
Dynamics of chronic myeloid leukaemia
F Michor, TP Hughes, Y Iwasa, S Branford, NP Shah, CL Sawyers, ...
Nature 435 (7046), 1267-1270, 2005
The mathematics of cancer: integrating quantitative models
PM Altrock, LL Liu, F Michor
Nature Reviews Cancer 15 (12), 730-745, 2015
Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity
A Marusyk, DP Tabassum, PM Altrock, V Almendro, F Michor, K Polyak
Nature 514 (7520), 54-58, 2014
Dynamics of cancer progression
F Michor, Y Iwasa, MA Nowak
Nature reviews cancer 4 (3), 197-205, 2004
Optimization of dosing for EGFR-mutant non–small cell lung cancer with evolutionary cancer modeling
J Chmielecki, J Foo, GR Oxnard, K Hutchinson, K Ohashi, R Somwar, ...
Science translational medicine 3 (90), 90ra59-90ra59, 2011
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
HC Bhang, DA Ruddy, V Krishnamurthy Radhakrishna, JX Caushi, ...
Nature medicine 21 (5), 440-448, 2015
Epidermal growth factor receptor tyrosine kinase inhibitor–resistant disease
K Ohashi, YE Maruvka, F Michor, W Pao
Journal of Clinical Oncology 31 (8), 1070-1080, 2013
Punctuated copy number evolution and clonal stasis in triple-negative breast cancer
R Gao, A Davis, TO McDonald, E Sei, X Shi, Y Wang, PC Tsai, ...
Nature genetics 48 (10), 1119-1130, 2016
Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies
H Haeno, M Gonen, MB Davis, JM Herman, CA Iacobuzio-Donahue, ...
Cell 148 (1), 362-375, 2012
Polyploidy can drive rapid adaptation in yeast
AM Selmecki, YE Maruvka, PA Richmond, M Guillet, N Shoresh, ...
Nature 519 (7543), 349-352, 2015
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia
A Klinakis, C Lobry, O Abdel-Wahab, P Oh, H Haeno, S Buonamici, ...
Nature 473 (7346), 230-233, 2011
Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma
T Ozawa, M Riester, YK Cheng, JT Huse, M Squatrito, K Helmy, N Charles, ...
Cancer cell 26 (2), 288-300, 2014
Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma
CJ Gibson, RC Lindsley, V Tchekmedyian, BG Mar, J Shi, S Jaiswal, ...
Journal of Clinical Oncology 35 (14), 1598-1605, 2017
Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
M Karaayvaz, S Cristea, SM Gillespie, AP Patel, R Mylvaganam, CC Luo, ...
Nature communications 9 (1), 3588, 2018
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype
SY Park, M Gönen, HJ Kim, F Michor, K Polyak
The Journal of clinical investigation 120 (2), 636-644, 2010
Synergy and discounting of cooperation in social dilemmas
C Hauert, F Michor, MA Nowak, M Doebeli
Journal of theoretical biology 239 (2), 195-202, 2006
Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity
V Almendro, YK Cheng, A Randles, S Itzkovitz, A Marusyk, E Ametller, ...
Cell reports 6 (3), 514-527, 2014
Successful therapy must eradicate cancer stem cells
D Dingli, F Michor
Stem cells 24 (12), 2603-2610, 2006
JAK–STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response
M Kleppe, M Kwak, P Koppikar, M Riester, M Keller, L Bastian, T Hricik, ...
Cancer discovery 5 (3), 316-331, 2015
The system can't perform the operation now. Try again later.
Articles 1–20